171 related articles for article (PubMed ID: 21530218)
1. Hepatitis B virus and renal transplantation.
Kalia H; Fabrizi F; Martin P
Transplant Rev (Orlando); 2011 Jul; 25(3):102-9. PubMed ID: 21530218
[TBL] [Abstract][Full Text] [Related]
2. Viral hepatitis in solid organ transplantation other than liver.
Vallet-Pichard A; Fontaine H; Mallet V; Pol S
J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
[TBL] [Abstract][Full Text] [Related]
3. HBV infection in patients with end-stage renal disease.
Fabrizi F; Bunnapradist S; Martin P
Semin Liver Dis; 2004; 24 Suppl 1():63-70. PubMed ID: 15192803
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection: implications in chronic kidney disease, dialysis and transplantation.
Ayodele OE; Salako BL; Kadiri S; Arije A; Alebiosu CO
Afr J Med Med Sci; 2006 Jun; 35(2):111-9. PubMed ID: 17209304
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis B virus and chronic progressive kidney disease].
Kes P; Slavicek J
Acta Med Croatica; 2009 Dec; 63(5):397-402. PubMed ID: 20198898
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus: from diagnosis to treatment.
Dény P; Zoulim F
Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of hepatitis B virus (HBV) infections with particular regard to current routes of transmission and development of cirrhosis and malignancy.
Norkrans G
Scand J Infect Dis Suppl; 1990; 69():43-7. PubMed ID: 2175941
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma (an approach to the study of risk factors in human cancer).
London WT
Ric Clin Lab; 1978; 8(4):232-6. PubMed ID: 216070
[TBL] [Abstract][Full Text] [Related]
10. Natural history of hepatitis B.
Marcellin P; Castelnau C; Martinot-Peignoux M; Boyer N
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):63-75. PubMed ID: 15756147
[TBL] [Abstract][Full Text] [Related]
11. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
12. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B in children: complexities in management.
Kerkar N
Pediatr Transplant; 2005 Oct; 9(5):685-91. PubMed ID: 16176431
[TBL] [Abstract][Full Text] [Related]
14. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection and liver transplantation.
Kennedy M; Alexopoulos SP
Curr Opin Organ Transplant; 2010 Jun; 15(3):310-5. PubMed ID: 20445447
[TBL] [Abstract][Full Text] [Related]
16. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
Wang FS; Zhang Z
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection and the dialysis patient.
Fabrizi F; Messa P; Martin P
Semin Dial; 2008; 21(5):440-6. PubMed ID: 18397202
[TBL] [Abstract][Full Text] [Related]
18. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
20. Impact of hepatitis B therapy on the long-term outcome of liver disease.
Liaw YF
Liver Int; 2011 Jan; 31 Suppl 1():117-21. PubMed ID: 21205148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
